Literature DB >> 15643003

Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.

Janine Valosky1, Haruka Hishiki, Theoklis E Zaoutis, Susan E Coffin.   

Abstract

The capacity of live or inactivated respiratory syncytial virus (RSV) to induce B-cell memory in respiratory-associated lymphoid tissues of mice was examined. Eight weeks after primary inoculation with either live or inactivated RSV, adult BALB/c mice were challenged with 4x10(5) PFU of RSV. Protection from viral shedding and mucosal production of RSV-specific antibodies were examined at various time points after challenge. We found that primary immunization with live, but not inactivated, RSV induced complete and durable protection upon challenge within the upper and lower respiratory tract. Also, primary immunization with live, but not inactivated, RSV enhanced the production of mucosal RSV-specific immunoglobulin A (IgA) upon challenge. Secondary mucosal IgA responses were characterized by (i) the early production of mucosal IgA by B cells that reside in organized nasal-associated lymphoid tissues, cervical lymph nodes, and bronchial lymph nodes, and (ii) the subsequent production of RSV-specific IgA by mucosal effector tissues, such as the tracheal lamina propria and lung. These findings suggest that primary infection of mice with live RSV might induce mucosal IgA-committed memory B cells. A greater understanding of the characteristics of RSA-specific mucosal memory B cells may facilitate the development of an RSV vaccine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643003      PMCID: PMC540216          DOI: 10.1128/CDLI.12.1.171-179.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

1.  Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen-specific B cells during the murine anti-rotavirus immune response.

Authors:  Kenneth R Youngman; Manuel A Franco; Nelly A Kuklin; Lusijah S Rott; Eugene C Butcher; Harry B Greenberg
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

2.  Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice.

Authors:  B Liang; L Hyland; S Hou
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Reinfection of mice with respiratory syncytial virus.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Med Virol       Date:  1991-05       Impact factor: 2.327

4.  Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model.

Authors:  A M Stack; R Malley; R A Saladino; J B Montana; K L MacDonald; D C Molrine
Journal:  Vaccine       Date:  2000-01-31       Impact factor: 3.641

5.  Immunity to and frequency of reinfection with respiratory syncytial virus.

Authors:  C B Hall; E E Walsh; C E Long; K C Schnabel
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

6.  Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

Authors:  R Weltzin; S A Hsu; E S Mittler; K Georgakopoulos; T P Monath
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Respiratory syncytial virus infection in anti-mu-treated mice.

Authors:  B S Graham; L A Bunton; J Rowland; P F Wright; D T Karzon
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Use of Peyer's patch and lymph node fragment cultures to compare local immune responses to Morganella morganii.

Authors:  A C Logan; K P Chow; A George; P D Weinstein; J J Cebra
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Short-term immunoglobulin A B-cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus.

Authors:  L Yuan; A Geyer; L J Saif
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

10.  Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs.

Authors:  R J Hogan; W Zhong; E J Usherwood; T Cookenham; A D Roberts; D L Woodland
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  6 in total

Review 1.  Mouse models for the study of mucosal vaccination against otitis media.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

Review 2.  Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

Authors:  Matthew R Olson; Steven M Varga
Journal:  Expert Rev Vaccines       Date:  2008-10       Impact factor: 5.217

3.  Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization.

Authors:  Shaswath S Chandrasekar; Yashdeep Phanse; Rachel E Hildebrand; Mostafa Hanafy; Chia-Wei Wu; Chungyi H Hansen; Jorge E Osorio; M Suresh; Adel M Talaat
Journal:  Vaccines (Basel)       Date:  2021-02-06

4.  Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept.

Authors:  Maria Fernanda Jabif; Emanuel Gumina; Jeffrey W Hall; Xochitl Hernandez-Velasco; Sherry Layton
Journal:  Front Vet Sci       Date:  2021-02-11

5.  Reference gene selection for gene expression study in shell gland and spleen of laying hens challenged with infectious bronchitis virus.

Authors:  Samiullah Khan; Juliet Roberts; Shu-Biao Wu
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

6.  Molecular mechanisms of primary and secondary mucosal immunity using avian infectious bronchitis virus as a model system.

Authors:  Xueshui Guo; Artur J M Rosa; Ding-Geng Chen; Xiuqing Wang
Journal:  Vet Immunol Immunopathol       Date:  2007-10-02       Impact factor: 2.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.